Heinrich-Heine-Universität Düsseldorf

TELERA-Asynchronous TELEmedicine for Patients With Rheumatoid Arthritis: Study Protocol for a Prospective, Multi-Center, Randomized Controlled Trial (2021) Mucke J, Knitza J, Muehlensiepen F, Grahammer M, Stenzel R, Simon D, Kleyer A, et al. Journal article Meta-analyses identify DNA methylation associated with kidney function and damage (2021) Schlosser P, Tin A, Matias-Garcia PR, Thio CHL, Joehanes R, Liu H, Weihs A, et al. Journal article Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus (2021) Tin A, Schlosser P, Matias-Garcia PR, Thio CHL, Joehanes R, Liu H, Yu Z, et al. Journal article Artificial intelligence-based automatic assessment of lower limb torsion on MRI (2021) Schock J, Truhn D, Nuernberger D, Conrad S, Huppertz MS, Keil S, Kuhl C, et al. Journal article Quantification of Sodium Relaxation Times and Concentrations as Surrogates of Proteoglycan Content of Patellar CARTILAGE at 3T MRI (2021) Kamp B, Frenken M, Henke JM, Abrar DB, Nagel AM, Gast L, Oeltzschner G, et al. Journal article Artificial extracellular matrices containing bioactive glass nanoparticles promote osteogenic differentiation in human mesenchymal stem cells (2021) Kroschwald LM, Allerdt F, Bernhardt A, Rother S, Zheng K, Maqsood I, Halfter N, et al. Journal article Digitalization: Just a buzzword or future progress? Digitalisierung: Nur Buzzword oder neuer Fortschritt? (2021) Hueber A, Richter J Journal article Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation (2021) Heydt C, Wölwer CB, Velazquez Camacho O, Wagener-Ryczek S, Pappesch R, Siemanowski J, Rehker J, et al. Journal article Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Conference contribution Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute BLymphoblastic Leukemia (INITIAL-1 trial) (2021) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution